Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access


Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne


Become EABM
Become Reviewer

Editorial: (Thematic Issue Cancer Immunotherapy: Does an Increasing Arsenal of Tools Point to More Fruitful Avenues for Research?) free to download

Volume:14   Issue: 2
Pp: 181-182
Bo Jin and Anthony E.T. Yeo
DOI: 10.2174/18715206113136660379

Poxvirus-Based Vaccines for Cancer Immunotherapy: New Insights from Combined Cytokines/Co-Stimulatory Molecules Delivery and “Uncommon” Strains

Volume:14   Issue: 2
Pp: 183-189
Valerio Izzi, Marcin Buler, Laura Masuelli, Maria G. Giganti, Andrea Modesti and Roberto Bei
DOI: 10.2174/18715206113136660376

The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-Immunotherapy

Volume:14   Issue: 2
Pp: 190-203
Helene van Meir, Gemma G. Kenter, Jacobus Burggraaf, Judith R. Kroep, Marij J.P. Welters, Cornelis J.M. Melief, Sjoerd H. van der Burg and Mariette I.E. van Poelgeest
DOI: 10.2174/18715206113136660372

CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer

Volume:14   Issue: 2
Pp: 204-210
Vy Phan-Lai, Forrest M. Kievit, Stephen J. Florczyk, Kui Wang, Mary L. Disis and Miqin Zhang
DOI: 10.2174/18715206113136660375

Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy

Volume:14   Issue: 2
Pp: 211-222
Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni, Maja Todorovic, Lidia Giraudo, Fabrizio Carnevale-Schianca, Massimo Aglietta and Dario Sangiolo
DOI: 10.2174/18715206113136660371

Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers

Volume:14   Issue: 2
Pp: 223-232
Martin Villalba, Nuria Lopez-Royuela, Ewelina Krzywinska, Moeez G. Rathore, Robert A. Hipskind, Houda Haouas and Nerea Allende-Vega
DOI: 10.2174/18715206113136660374

The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention open access plus

Volume:14   Issue: 2
Pp: 233-240
Georgia Schäfer and Catherine H. Kaschula
DOI: 10.2174/18715206113136660370

Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends

Volume:14   Issue: 2
Pp: 241-255
Bo Jin, Liu-Fang Cheng, Kai Wu, Xiao-Hong Yu and Anthony E.T. Yeo
DOI: 10.2174/18715206113136660373

HPV-Specific Immunotherapy: Key Role for Immunomodulators

Volume:14   Issue: 2
Pp: 265-279
Stephanie Van de Wall, Hans W Nijman and Toos Daemen
DOI: 10.2174/187152061402140128163306

Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer

Volume:14   Issue: 2
Pp: 280-289
Chunhua Zhang, Zheng Zhang, Yuechun Zhu and Suofu Qin
DOI: 10.2174/18715206113136660337

Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies

Volume:14   Issue: 2
Pp: 296-312
Francesco Moccia, Silvia Dragoni, Valentina Poletto, Vittorio Rosti, Franco Tanzi, Carlo Ganini and Camillo Porta
DOI: 10.2174/18715206113139990315

Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines

Volume:14   Issue: 2
Pp: 313-318
Georg Karpel-Massler, Mike-Andrew Westhoff, Richard E. Kast, Annika Dwucet, Lisa Nonnenmacher, C. Rainer Wirtz, Klaus-Michael Debatin and Marc-Eric Halatsch
DOI: 10.2174/18715206113136660340

Electrochemical Study of Ellipticine Interaction with Single and Double Stranded Oligonucleotides

Volume:14   Issue: 2
Pp: 331-340
Katerina Tmejova, Ludmila Krejcova, David Hynek, Vojtech Adam, Petr Babula, Libuse Trnkova, Marie Stiborova, Tomas Eckschlager and Rene Kizek
DOI: 10.2174/18715206113139990316